ECSP066918A - Derivados de piridoindolona sustituidos en -6, su preparación y su aplicación en terapéutica - Google Patents

Derivados de piridoindolona sustituidos en -6, su preparación y su aplicación en terapéutica

Info

Publication number
ECSP066918A
ECSP066918A EC2006006918A ECSP066918A ECSP066918A EC SP066918 A ECSP066918 A EC SP066918A EC 2006006918 A EC2006006918 A EC 2006006918A EC SP066918 A ECSP066918 A EC SP066918A EC SP066918 A ECSP066918 A EC SP066918A
Authority
EC
Ecuador
Prior art keywords
therapeutics
preparation
application
substituted
piridoindolona
Prior art date
Application number
EC2006006918A
Other languages
English (en)
Inventor
Pierre Casellas
Samir Jegham
Bernard Bourrie
Paola Ciapetti
Jean Marie Derocq
Yvette Muneaux
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ECSP066918A publication Critical patent/ECSP066918A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención tiene como objetivo compuestos que responden a la fórmula: en la que:- R1 representa un átomo de hidrógeno; un grupo alquilo (C1-C4); un grupo -(CH2)mOH; un grupo -(CH2)mCN; un grupo -(CH2)mNR9R10;- R2 representa un átomo de hidrógeno o un grupo alquilo (C1-C4);- R3 representa un fenilo sustituido con R6, R7, R8;- R4 representa: . un radical heterocíclico elegido entre: - R5 representa un átomo de hidrógeno o un grupo alquilo (C1-C4);Procedimiento de preparación y aplicación en terapéutica.
EC2006006918A 2004-04-21 2006-10-11 Derivados de piridoindolona sustituidos en -6, su preparación y su aplicación en terapéutica ECSP066918A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0404251A FR2869316B1 (fr) 2004-04-21 2004-04-21 Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
PCT/FR2005/000971 WO2005108398A1 (fr) 2004-04-21 2005-04-20 Derives de pyridoindolone substitues en -6, leur preparation, leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ECSP066918A true ECSP066918A (es) 2007-01-26

Family

ID=34945552

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006918A ECSP066918A (es) 2004-04-21 2006-10-11 Derivados de piridoindolona sustituidos en -6, su preparación y su aplicación en terapéutica

Country Status (31)

Country Link
US (1) US7812165B2 (es)
EP (1) EP1742947B1 (es)
JP (1) JP4809830B2 (es)
KR (1) KR20070002094A (es)
CN (1) CN100537568C (es)
AR (1) AR048932A1 (es)
AT (1) ATE405565T1 (es)
AU (1) AU2005240816A1 (es)
BR (1) BRPI0510060A (es)
CA (1) CA2562561A1 (es)
CR (1) CR8677A (es)
DE (1) DE602005009166D1 (es)
DK (1) DK1742947T3 (es)
EC (1) ECSP066918A (es)
ES (1) ES2313371T3 (es)
FR (1) FR2869316B1 (es)
HK (1) HK1106223A1 (es)
IL (1) IL178444A0 (es)
MA (1) MA28546B1 (es)
MX (1) MXPA06012127A (es)
MY (1) MY137599A (es)
NO (1) NO20065323L (es)
PL (1) PL1742947T3 (es)
PT (1) PT1742947E (es)
RU (1) RU2364595C2 (es)
TN (1) TNSN06337A1 (es)
TW (1) TW200538114A (es)
UA (1) UA85709C2 (es)
UY (1) UY28864A1 (es)
WO (1) WO2005108398A1 (es)
ZA (1) ZA200608646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
DE69535703T2 (de) 1994-04-13 2009-02-19 The Rockefeller University AAV-vermittelte Zufuhr von DNA an Zellen des Nervensystems
DE19502753A1 (de) 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
US6291473B1 (en) 1998-04-02 2001-09-18 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9H-pyridino [2, 3-B] indole and 5,6,7,8-tetrahydro-9H-pyrimidino [4, 5-B] indole derivatives: CRF1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
TNSN06337A1 (en) 2008-02-22
WO2005108398A1 (fr) 2005-11-17
KR20070002094A (ko) 2007-01-04
US20070129365A1 (en) 2007-06-07
PT1742947E (pt) 2008-11-25
DE602005009166D1 (de) 2008-10-02
JP2007533710A (ja) 2007-11-22
JP4809830B2 (ja) 2011-11-09
CN100537568C (zh) 2009-09-09
FR2869316B1 (fr) 2006-06-02
MXPA06012127A (es) 2007-01-31
AR048932A1 (es) 2006-06-14
EP1742947A1 (fr) 2007-01-17
CN1956986A (zh) 2007-05-02
IL178444A0 (en) 2007-02-11
CA2562561A1 (fr) 2005-11-17
RU2006140998A (ru) 2008-05-27
TW200538114A (en) 2005-12-01
MY137599A (en) 2009-02-27
DK1742947T3 (da) 2009-01-05
MA28546B1 (fr) 2007-04-03
FR2869316A1 (fr) 2005-10-28
AU2005240816A1 (en) 2005-11-17
BRPI0510060A (pt) 2007-10-16
ZA200608646B (en) 2008-02-27
UA85709C2 (ru) 2009-02-25
EP1742947B1 (fr) 2008-08-20
ES2313371T3 (es) 2009-03-01
ATE405565T1 (de) 2008-09-15
CR8677A (es) 2007-08-28
NO20065323L (no) 2006-12-08
HK1106223A1 (en) 2008-03-07
US7812165B2 (en) 2010-10-12
PL1742947T3 (pl) 2009-01-30
RU2364595C2 (ru) 2009-08-20
UY28864A1 (es) 2005-11-30

Similar Documents

Publication Publication Date Title
DOP2006000043A (es) Derivados del 1,5-diarilpirrol, su preparación y su aplicación en terapeútica
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
PA8639301A1 (es) Derivados de piridio-pirimidina, su preparacion, su enterapeutica
NO20090313L (no) Derivater og analoger av N-etylkinoloner og N-etylazakinoloner
BR112015019790A2 (pt) derivado de piridina monocíclica
CR8468A (es) Derivado de n-(1,5-difenil-1h-pirazol-3-il)metil)sulfonamida con afinidad por los receptores cb1
CY1111758T1 (el) Τρικυκλικες ενωσεις και χρηση αυτων ως ρυθμιστες υποδοχεα γλυκοκορτικοειδους
UY28855A1 (es) Derivados de la 1-amino-ftalazina su preparación y su uso en terapia
ATE523486T1 (de) Pleuromutilinderivate zur behandlung von durch mikroben vermittelten krankheiten
CY1114067T1 (el) Παραγωγα πυρρολιδιν-2-ονης ως ρυθμιστες υποδοχεα ανδρογονων
TNSN08311A1 (en) Indole sulfonamide modulators of progesterone receptors
BRPI0608216A2 (pt) agente terapêutico para um tumor, método para tratar um tumor, e, uso de um composto de benzoìla, uma pró-groga do mesmo ou um sal farmaceuticamente aceitável do mesmo
AR070485A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
DOP2007000067A (es) Derivados de aminometilpiridina, su preparación y su aplicación en terapéutica
DE602007006328D1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
DOP2006000133A (es) Derivados de 4,5 diarilpiroxol, su preparación y su aplicación en terapeútica
AR076362A1 (es) Arilsulfonamidas 2,5-disustituidas antagonistas de ccr3, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento y/o prevencion de patologias autoinmunes e inflamatorias, entre otras.
CR9873A (es) Derivados de 6-heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica
ECSP066918A (es) Derivados de piridoindolona sustituidos en -6, su preparación y su aplicación en terapéutica
MX2007015130A (es) Nuevos derivados de pirroliltriazina asi como procedimientos para su obtencion y su utilizacion como agentes protectores contra la radiacion uv.
ECSP099738A (es) Derivados de pirazolona como inhibidores de pde4
UY29054A1 (es) Derivados de pirro, su preparación y su aplicación en terapeutica